Accepted Manuscript Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Megan C. Turner, MD, Norma E. Farrow, MD, Kristen E. Rhodin, BS, Zhifei Sun, MD, Mohamed A. Adam, MD, Christopher R. Mantyh, MD, FACS, John Migaly, MD, FACS PII: S1072-7515(18)30029-2 DOI: 10.1016/j.jamcollsurg.2017.12.048 Reference: ACS 9003 To appear in: Journal of the American College of Surgeons Received Date: 13 December 2017 Accepted Date: 14 December 2017 Please cite this article as: Turner MC, Farrow NE, Rhodin KE, Sun Z, Adam MA, Mantyh CR, Migaly J, Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer, Journal of the American College of Surgeons (2018), doi: 10.1016/j.jamcollsurg.2017.12.048. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.